Associations between Genetic Polymorphisms in IL-33, IL1R1 and Risk for Inflammatory Bowel Disease

PLoS ONE

Volumn 8, Issue 4, 2013, Pages

  Latiano, Anna ^a   Palmieri, Orazio ^a   Pastorelli, Luca ^b,g   Vecchi, Maurizio ^b,g   Pizarro, Theresa T ^c   Bossa, Fabrizio ^a   Merla, Giuseppe ^a   Augello, Bartolomeo ^a   Latiano, Tiziana ^a   Corritore, Giuseppe ^a   Settesoldi, Alessia ^d   Valvano, Maria Rosa ^a   D'Incà, Renata ^e   Stronati, Laura ^f   Annese, Vito ^d   Andriulli, Angelo ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^b IRCCS POLICLINICO SAN DONATO   (Italy)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CAREGGI UNIVERSITY HOSPITAL   (Italy)

^e UNIVERSITY OF PADOVA   (Italy)

^f ENEA   (Italy)

^g UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR TYPE I; INTERLEUKIN 33; MESSENGER RNA; IL1R1 PROTEIN, HUMAN; IL33 PROTEIN, HUMAN; INTERLEUKIN DERIVATIVE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CLINICAL EVALUATION; COLON BIOPSY; CONTROLLED STUDY; CROHN DISEASE; ETHNIC GROUP; FEMALE; GENE EXPRESSION REGULATION; GENE FREQUENCY; GENE FUNCTION; GENE LOCATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HETEROZYGOTE; HOMOZYGOTE; HUMAN; HUMAN TISSUE; INTERLEUKIN 1 RECEPTOR TYPE I GENE; INTERLEUKIN 33 GENE; ITALY; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRESCHOOL CHILD; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; ULCERATIVE COLITIS; ADOLESCENT; CASE CONTROL STUDY; COHORT ANALYSIS; COLITIS, ULCERATIVE; GENETIC PREDISPOSITION; GENETICS; HAPLOTYPE; INFANT; MIDDLE AGED; PHENOTYPE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGE OF ONSET; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; COLITIS, ULCERATIVE; CROHN DISEASE; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; INFANT; INTERLEUKINS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, INTERLEUKIN-1 TYPE I; YOUNG ADULT;

EID: 84876740406     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0062144     Document Type: Article

References (66)

1. Kaser A, Zeissig S, Blumberg RS, (2010) Inflammatory bowel disease. Annu Rev Immunol 28: 573-621.
2. Kim SW, Kim ES, Moon CM, Park JJ, Kim TI, et al. (2011) Genetic polymorphisms of IL-23R and IL-17A and novel insights into their associations with inflammatory bowel disease Gut. 60: 1527-1536.
3. Andersen V, Ernst A, Christensen J, Østergaard M, Jacobsen BA, et al. (2010) The polymorphism rs3024505 proximal to IL-10 is associated with risk of ulcerative colitis and Crohns disease in a Danish case-control study. BMC Med Genet 11: 82.
4. Palmieri O, Latiano A, Salvatori E, Valvano MR, Bossa F, et al. (2010) The-A2518G polymorphism of monocyte chemoattractant protein-1 is associated with Crohn's disease. Am J Gastroentero 105: 1586-1594.
5. Nemetz A, Nosti-Escanilla MP, Molnár T, Köpe A, Kovács A, et al. (1999) IL1B gene polymorphisms influence the course and severity of inflammatory bowel disease. Immunogenetics 49: 527-531.
6. Stokkers PC, van Aken BE, Basoski N, Reitsma PH, Tytgat GN, et al. (1998) Five genetic markers in the interleukin 1 family in relation to inflammatory bowel disease. Gut 43: 33-39.
7. Tamura K, Fukuda Y, Sashio H, Takeda N, Bamba H, et al. (2002) IL18 polymorphism is associated with an increased risk of Crohn's disease. J Gastroenterol 37Suppl 14: 111-116.
8. Aizawa Y, Sutoh S, Matsuoka M, Negishi M, Torii A, et al. (2005) Association of interleukin-18 gene single-nucleotide polymorphisms with susceptibility to inflammatory bowel disease. Tissue Antigens 65: 88-92.
9. Glas J, Török HP, Tonenchi L, Kapser J, Schiemann U, et al. (2005) Association of polymorphisms in the interleukin-18 gene in patients with Crohn's disease depending on the CARD15/NOD2 genotype. Inflamm Bowel Dis 11: 1031-1037.
10. Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, et al. (2005) IL- 33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23: 479-490.
11. Smithgall MD, Comeau MR, Yoon BR, Kaufman D, Armitage R, Smith DE, (2008) IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK cells. Int Immunol 20: 1019-1030.
12. Xu D, Jiang HR, Kewin P, Li Y, Mu R, et al. (2008) IL-33 exacerbates antigen-induced arthritis by activating mast cells. Proc Natl Acad Sci U S A 105: 10913-10918.
13. Palmer G, Talabot-Ayer D, Lamacchia C Toy D, Seemayer CA, et al. (2009) Inhibition of interleukin-33 signaling attenuates the severity of experimental arthritis. Arthritis Rheum 60: 738-749.
14. Chackerian AA, Oldham ER, Murphy EE, Schmitz J, Pflanz S, Kastelein RA, (2007) IL-1 receptor accessory protein and ST2 comprise the IL-33 receptor complex. J Immunol 179: 2551-2555.
15. Hayakawa H, Hayakawa M, Kume A, Tominaga S, (2007) Soluble ST2 blocks interleukin-33 signaling in allergic airway inflammation. J Biol Chem 282: 26369-26380.
16. Li M, Li Y, Liu X, Gao X, Wang Y, (2012) IL-33 blockade suppresses the development of experimental autoimmune encephalomyelitis in C57BL/6 mice. J Neuroimmunol 247: 25-31.
17. Pushparaj PN, Tay HK, H'ng SC, Pitman N, Xu D, et al. (2009) The cytokine interleukin-33 mediates anaphylactic shock. Proc Natl Acad Sci U S A 106: 9773-9778.
18. Miller AM, Xu D, Asquith DL, Denby L, Li Y, et al. (2008) IL-33 reduces the development of atherosclerosis. J Exp Med 205: 339-346.
19. Volarevic V, Mitrovic M, Milovanovic M, Zelen I, Nikolic I, et al. (2012) Protective role of IL-33/ST2 axis in Con A-induced hepatitis. J Hepatol 56: 26-33.
20. Chapuis J, Hot D, Hansmannel F, Kerdraon O, Ferreira S, et al. (2009) Transcriptomic and genetic studies identify IL-33 as a candidate gene for Alzheimer's disease. Mol Psychiatry 14: 1004-1016.
21. Gudbjartsson DF, Bjornsdottir US, Halapi E, Helgadottir A, Sulem P, et al. (2009) Sequence variants affecting eosinophil numbers associate with asthma and myocardial infarction. Nat Genet 41: 342-347.
22. Bossé Y, Lemire M, Poon AH, Daley D, He JQ, et al. (2009) Asthma and genes encoding components of the vitamin D pathway. Respir Res 10: 98.
23. Wu H, Romieu I, Shi M, Hancock DB, Li H, et al. (2010) Evaluation of candidate genes in a genome-wide association study of childhood asthma in Mexicans. J Allergy Clin Immunol 125: 321-327.
24. Buysschaert ID, Grulois V, Eloy P, Jorissen M, Rombaux P, et al. (2010) Genetic evidence for a role of IL33 in nasal polyposis. Allergy 65: 616-622.
25. Castano R, Bossé Y, Endam LM, Desrosiers M, (2009) Evidence of association of interleukin-1 receptor-like 1 gene polymorphisms with chronic rhinosinusitis. Am J Rhinol Allergy 23: 377-384.
26. Shimizu M, Matsuda A, Yanagisawa K, Hirota T, Akahoshi M, et al. (2005) Functional SNPs in the distal promoter of the ST2 gene are associated with atopic dermatitis. Hum Mol Genet 14: 2919-2927.
27. Seidelin JB, Bjerrum JT, Coskun M, Widjaya B, Vainer B, Nielsen OH, (2010) IL-33 is upregulated in colonocytes of ulcerative colitis. Immunol Lett 128: 80-85.
28. Beltrán CJ, Núñez LE, Díaz-Jiménez D, Farfan N, Candia E, et al. (2010) Characterization of the novel ST2/IL-33 system in patients with inflammatory bowel disease. Inflamm Bowel Dis 16: 1097-1107.
29. Pastorelli L, Garg RR, Hoang SB, Spina L, Mattioli B, et al. (2010) Epithelial-derived IL-33 and its receptor ST2 are dysregulated in ulcerative colitis and in experimental Th1/Th2 driven enteritis. Proc Natl Acad Sci U S A 107: 8017-8022.
30. Kobori A, Yagi Y, Imaeda H, Ban H, Bamba S, et al. (2010) Interleukin-33 expression is specifically enhanced in inflamed mucosa of ulcerative colitis. J Gastroenterol 45: 999-1007.
31. Sponheim J, Pollheimer J, Olsen T, Balogh J, Hammarström C, et al. (2010) Inflammatory bowel disease-associated interleukin-33 is preferentially expressed in ulceration-associated myofibroblasts. Am J Pathol 177: 2804-2815.
32. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, et al. (2005) Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 19 (suppl A): 5-36.
33. International HapMap Project. Database of genes associated with human disease and response to pharmaceuticals [HapMap web site]. Available from: www.hapmap.org.
34. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
35. Franke A, McGovern DPB, Barrett JC, Wang K, Radford-Smith GL, et al. (2010) Genome-wide metaanalysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 42: 1118-1125.
36. Anderson CA, Boucher G, Lees CW, Franke A, D'Amato M, et al. (2011) Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 43: 246-452.
37. McGovern DP, Gardet A, Törkvist L, Goyette P, Essers J, et al. (2010) Genome-wide association identifies multiple ulcerative colitis susceptibility loci. Nat Genet 42: 332-337.
38. Koskinen LL, Einarsdottir E, Dukes E, Heap GA, Dubois P, et al. (2009) Association study of the IL18RAP locus in three European populations with celiac disease. Hum Mol Genet 18: 1148-1155.
39. Cucchiara S, Latiano A, Palmieri O, Canani RB, D'Incà R, et al. (2007) Polymorphisms of tumor necrosis factor-alpha but not MDR1 influence response to medical therapy in pediatric-onset inflammatory bowel disease. J Pediatr Gastroenterol Nutr 44: 171-179.
40. Cominelli F, (2004) Cytokine-based therapies for Crohn's disease-new paradigms. N Engl J Med 351: 2045-2048.
41. Strober W, Fuss I, Mannon P, (2007) The fundamental basis of inflammatory bowel disease. J Clin Invest 117: 514-521.
42. Mitcham JL, Parnet P, Bonnert TP, Garka KE, Gerhart MJ, et al. (1996) T1/ST2 signaling establishes it as a member of an expanding interleukin-1 receptor family. J. Biol. Chem 271: 5777-5783.
43. Oboki K, Ohno T, Kajiwara N, Saito H, Nakae S, (2010) IL-33 and IL-33 receptors in host defense and diseases. Allergol Int 59: 143-160.
44. Kearley J, Buckland KF, Mathie SA, Lloyd CM, (2009) Resolution of allergic inflammation and airway hyperreactivity is dependent upon disruption of the T1/ST2-IL-33 pathway. Am J Respir Crit Care Med 179: 772-781.
45. Iikura M, Suto H, Kajiwara N, Oboki K, Ohno T, et al. (2007) IL-33 can promote survival, adhesion and cytokine production in human mast cells. Lab Invest 87: 971-978.
46. Imielinski M, Baldassano RN, Griffiths A, Russell RK, Annese V, et al. (2009) Common variants at five new loci associated with early-onset inflammatory bowel disease. Nat Genet 41: 1335-1340.
47. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, et al. (2012) Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491: 119-124.
48. Van Limbergen J, Wilson DC, Satsangi J, (2009) The genetics of Crohn's disease. Annu Rev Genomics Human Genet 10: 89-116.
49. Smith AM, Rahman FZ, Hayee B, Graham SJ, Marks DJ, et al. (2009) Disordered macrophage cytokine secretion underlies impaired acute inflammation and bacterial clearance in Crohn's disease. J Exp Med 206: 1883-1897.
50. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, et al. (2001) A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411: 603-606.
51. Hampe J, Franke A, Rosenstiel P, Till A, Teuber M, et al. (2007) A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat Genet 39: 207-211.
52. Rioux JD, Xavier RJ, Taylor KD, Silverberg MS, Goyette P, et al. (2007) Genome-wide association study identifies new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat Genet 39: 596-604.
53. Villani AC, Lemire M, Fortin G, Louis E, Silverberg MS, et al. (2009) Common variants in the NLRP3 region contribute to Crohn's disease susceptibility. Nat Genet 41: 71-76.
54. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cézard JP, et al. (2001) Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411: 599-603.
55. Parkes M, Barrett JC, Prescott NJ, Tremelling M, Anderson CA, et al. (2007) Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat Genet 39: 830-832.
56. Lees CW, Barrett JC, Parkes M Satsangi J, (2011) New IBD genetics: common pathways with other diseases. Gut 60: 1739-1753.
57. Seldin MF, Amos CI, (2009) Shared susceptibility variations in autoimmune diseases: a brief perspective on common issues. Genes Immun 10: 1-4.
58. Duan L, Chen J, Zhang H, Yang H, Zhu P, et al. (2012) IL-33 ameliorates experimental colitis through promoting Th2/Foxp3(+) Treg responses in mice. Mol Med Mar 12. Epub ahead of print.
59. Oboki K, Ohno T, Kajiwara N, Arae K, Morita H, et al. (2010) IL-33 is a crucial amplifier of innate rather than acquired immunity. Proc Natl Acad Sci U S A 107: 18581-18586.
60. Imaeda H, Andoh A, Aomatsu T, Uchiyama K, Bamba S, et al. (2011) Interleukin-33 suppresses Notch ligand expression and prevents goblet cell depletion in dextran sulfate sodium-induced colitis. Int J Mol Med 28: 573-578.
61. Groβ P, Doser K, Falk W, Obermeier F, Hofmann C (2012) IL-33 attenuates development and perpetuation of chronic intestinal inflammation. Inflamm Bowel Dis Apr 16. Epub ahead of print.
62. Pastorelli L, De Salvo C, Cominelli MA, Vecchi M, Pizarro TT, (2011) Novel cytokine signaling pathways in inflammatory bowel disease: insight into the dichotomous functions of IL-33 during chronic intestinal inflammation. Therap Adv Gastroenterol 4: 311-323.
63. Oshikawa K, Yanagisawa K, Tominaga S, Sugiyama Y, (2002) Expression and function of the ST2 gene in a murine model of allergic airway inflammation. Clin Exp Allergy 32: 1520-1526.
64. Plaza-Izurieta L, Castellanos-Rubio A, Irastorza I, Fernández-Jimenez N, Gutierrez G, et al. (2011) Revisiting genome wide association studies (GWAS) in coeliac disease: replication study in Spanish population and expression analysis of candidate genes. J Med Genet 48: 493-496.
65. Luzina IG, Pickering EM, Kopach P, Kang PH, Lockatell V, et al. (2012) Full-Length IL-33 Promotes Inflammation but not Th2 Response In Vivo in an ST2-Independent Fashion. J Immunol 189: 403-410.
66. Carriere V, Roussel L, Ortega N, Lacorre DA, Americh L, et al. (2007) IL-33, the IL-1-like cytokine ligand for ST2 receptor, is a chromatin-associated nuclear factor in vivo. Proc Natl Acad Sci U S A 104: 282-287.